Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 8, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-06-26
DOI
10.1038/s41408-018-0100-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
- (2018) Tiziano Barbui et al. LEUKEMIA
- Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
- (2018) Dawid T. Janczak et al. MAYO CLINIC PROCEEDINGS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
- (2018) Tiziano Barbui et al. Blood Cancer Journal
- Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
- (2017) Francesco Passamonti et al. LANCET ONCOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial
- (2016) H. K. Al-Ali et al. HAEMATOLOGICA
- Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis
- (2016) Carlos Noronha Ferreira et al. HEPATOLOGY
- Direct oral anticoagulants in rare venous thrombosis
- (2016) Guido Finazzi et al. Internal and Emergency Medicine
- Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
- (2016) M Marchetti et al. LEUKEMIA
- Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
- (2016) Andrea De Gottardi et al. LIVER INTERNATIONAL
- Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment
- (2016) Silvia Betti et al. THROMBOSIS AND HAEMOSTASIS
- OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism
- (2016) A. Young et al. THROMBOSIS RESEARCH
- Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
- (2016) V De Stefano et al. Blood Cancer Journal
- Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial
- (2016) H. K. Al-Ali et al. HAEMATOLOGICA
- Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review
- (2016) Nosha Farhadfar et al. Journal of Oncology Practice
- Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial
- (2015) Adam J. Mead et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
- (2015) N M Kröger et al. LEUKEMIA
- Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
- (2015) Umberto Gianelli et al. LEUKEMIA RESEARCH
- Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms
- (2015) Andrej Potthoff et al. LIVER INTERNATIONAL
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- How I treat splanchnic vein thrombosis
- (2014) W. Ageno et al. BLOOD
- A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
- (2014) Federico Lussana et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
- (2014) Bruno Cassinat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Etiology, Management, and Outcome of the Budd-Chiari Syndrome
- (2013) Sarwa Darwish Murad ANNALS OF INTERNAL MEDICINE
- Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
- (2013) G. Barosi et al. BLOOD
- Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
- (2013) H. Gisslinger et al. BLOOD
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
- Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon -2a
- (2013) A. Quintas-Cardama et al. BLOOD
- Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper
- (2013) Giovanni Barosi et al. LEUKEMIA RESEARCH
- Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
- (2012) J. H. Smalberg et al. BLOOD
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in budd-chiari syndrome and their impact on thrombotic complications post Liver Transplantation
- (2012) Rachel H. Westbrook et al. LIVER TRANSPLANTATION
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
- (2011) J. HOEKSTRA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Long-Term Follow-Up of Liver Transplantation for Budd-Chiari Syndrome With Antithrombotic Therapy Based on the Etiology
- (2011) Srinath Chinnakotla et al. TRANSPLANTATION
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- (2009) F. Dentali et al. BLOOD
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
- (2009) F. Passamonti et al. BLOOD
- A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process
- (2009) Giovanni Barosi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Survival and Recurrence in Patients With Splanchnic Vein Thromboses
- (2009) Mallikarjun R. Thatipelli et al. Clinical Gastroenterology and Hepatology
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- (2008) F. Cervantes et al. BLOOD
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started